CN101831397A - 一种大肠杆菌和使用该大肠杆菌制备l-半胱氨酸的方法 - Google Patents
一种大肠杆菌和使用该大肠杆菌制备l-半胱氨酸的方法 Download PDFInfo
- Publication number
- CN101831397A CN101831397A CN 201010136361 CN201010136361A CN101831397A CN 101831397 A CN101831397 A CN 101831397A CN 201010136361 CN201010136361 CN 201010136361 CN 201010136361 A CN201010136361 A CN 201010136361A CN 101831397 A CN101831397 A CN 101831397A
- Authority
- CN
- China
- Prior art keywords
- gene
- halfcystine
- intestinal bacteria
- coli
- cysteine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 23
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 title abstract description 22
- 239000004201 L-cysteine Substances 0.000 title abstract description 7
- 235000013878 L-cysteine Nutrition 0.000 title abstract description 7
- 238000000855 fermentation Methods 0.000 claims abstract description 28
- 230000004151 fermentation Effects 0.000 claims abstract description 28
- 108091022908 Serine O-acetyltransferase Proteins 0.000 claims abstract description 25
- 101150019860 gshA gene Proteins 0.000 claims abstract description 25
- 101150117293 metC gene Proteins 0.000 claims abstract description 25
- 101150099895 tnaA gene Proteins 0.000 claims abstract description 25
- 101100076641 Bacillus subtilis (strain 168) metE gene Proteins 0.000 claims abstract description 23
- 101100015982 Dictyostelium discoideum gcsA gene Proteins 0.000 claims abstract description 23
- 101100172084 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) egtA gene Proteins 0.000 claims abstract description 23
- 101150057540 aar gene Proteins 0.000 claims abstract description 23
- 239000001963 growth medium Substances 0.000 claims abstract description 15
- 238000011218 seed culture Methods 0.000 claims abstract description 15
- 241000894006 Bacteria Species 0.000 claims description 40
- 230000000968 intestinal effect Effects 0.000 claims description 35
- 239000002609 medium Substances 0.000 claims description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 238000011534 incubation Methods 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- SVOZWQVJNZEQFC-UHFFFAOYSA-M S(=O)(=O)([O-])[O-].Cl[NH3+].[Na+] Chemical compound S(=O)(=O)([O-])[O-].Cl[NH3+].[Na+] SVOZWQVJNZEQFC-UHFFFAOYSA-M 0.000 claims description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- -1 extractum carnis Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 claims description 3
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 3
- 229940038773 trisodium citrate Drugs 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 239000000758 substrate Substances 0.000 abstract description 5
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 abstract 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 101150111114 cysE gene Proteins 0.000 description 21
- 101100498063 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) cysB gene Proteins 0.000 description 18
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 18
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 15
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 14
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 13
- 230000009466 transformation Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 9
- 101150049556 Bcr gene Proteins 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000012239 gene modification Methods 0.000 description 6
- 230000005017 genetic modification Effects 0.000 description 6
- 235000013617 genetically modified food Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000020018 Cystathionine gamma-Lyase Human genes 0.000 description 5
- 108010045283 Cystathionine gamma-lyase Proteins 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- 108060004316 L-cysteine desulfidase Proteins 0.000 description 2
- 102100022923 Phosphopantothenate-cysteine ligase Human genes 0.000 description 2
- 101710107870 Phosphopantothenate-cysteine ligase Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 102220023258 rs387907548 Human genes 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- XQDQRCRASHAZBA-UHFFFAOYSA-N 2,4-dinitro-1-thiocyanatobenzene Chemical compound [O-][N+](=O)C1=CC=C(SC#N)C([N+]([O-])=O)=C1 XQDQRCRASHAZBA-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 101001058938 Acidaminococcus fermentans (strain ATCC 25085 / DSM 20731 / CCUG 9996 / CIP 106432 / VR4) Glutaconyl-CoA decarboxylase subunit beta Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108010076010 Cystathionine beta-lyase Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- VZXPDPZARILFQX-BYPYZUCNSA-N O-acetyl-L-serine Chemical compound CC(=O)OC[C@H]([NH3+])C([O-])=O VZXPDPZARILFQX-BYPYZUCNSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 102220004457 rs11567847 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 238000012868 site-directed mutagenesis technique Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
实施例 | 发酵温度(℃) | 发酵时间(小时) | 摇瓶转速(转/分钟) | L-半胱氨酸产量(毫克/升) |
实施例2 | 30 | 48 | 200 | 290 |
实施例3 | 35 | 48 | 200 | 811 |
实施例4 | 37 | 48 | 200 | 1050 |
实施例5 | 40 | 48 | 200 | 794 |
实施例6 | 45 | 48 | 200 | 188 |
实施例7 | 37 | 24 | 200 | 222 |
实施例8 | 37 | 36 | 200 | 818 |
实施例9 | 37 | 60 | 200 | 800 |
实施例10 | 37 | 72 | 200 | 196 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101363610A CN101831397B (zh) | 2010-03-30 | 2010-03-30 | 一种大肠杆菌和使用该大肠杆菌制备l-半胱氨酸的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101363610A CN101831397B (zh) | 2010-03-30 | 2010-03-30 | 一种大肠杆菌和使用该大肠杆菌制备l-半胱氨酸的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101831397A true CN101831397A (zh) | 2010-09-15 |
CN101831397B CN101831397B (zh) | 2012-01-25 |
Family
ID=42715617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101363610A Active CN101831397B (zh) | 2010-03-30 | 2010-03-30 | 一种大肠杆菌和使用该大肠杆菌制备l-半胱氨酸的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101831397B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016082923A (ja) * | 2014-10-27 | 2016-05-19 | 大陽日酸株式会社 | 大腸菌変異体、抽出液、無細胞タンパク質合成反応液、安定同位体標識タンパク質合成キット、及び、安定同位体標識タンパク質の製造方法 |
EP3098319A1 (en) | 2015-05-28 | 2016-11-30 | Ajinomoto Co., Inc. | A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having an attenuated expression of a gsha gene |
CN111979206A (zh) * | 2019-05-24 | 2020-11-24 | 深圳瑞德林生物技术有限公司 | 固定化融合酶及用其制备谷胱甘肽的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286368A (zh) * | 1999-08-26 | 2001-03-07 | 东尾机械株式会社 | 管接头 |
-
2010
- 2010-03-30 CN CN2010101363610A patent/CN101831397B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286368A (zh) * | 1999-08-26 | 2001-03-07 | 东尾机械株式会社 | 管接头 |
Non-Patent Citations (3)
Title |
---|
《Eur J Biochem》 19991130 Inoue K ect.al Determination of the sites required for the allosteric inhibition of serine acetyltransferase by L-cysteine in plants. 220-227 1-6 , 2 * |
《基因工程》 20060630 孙明 细菌基因工程 300-305 , 1 * |
《食品科学》 20090901 梅艳珍等 微生物法制备L-半胱氨酸及其代谢调节研究进展 345-348 第30卷, 第17期 2 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016082923A (ja) * | 2014-10-27 | 2016-05-19 | 大陽日酸株式会社 | 大腸菌変異体、抽出液、無細胞タンパク質合成反応液、安定同位体標識タンパク質合成キット、及び、安定同位体標識タンパク質の製造方法 |
EP3098319A1 (en) | 2015-05-28 | 2016-11-30 | Ajinomoto Co., Inc. | A method for producing an l-amino acid using a bacterium of the family enterobacteriaceae having an attenuated expression of a gsha gene |
US20160348089A1 (en) * | 2015-05-28 | 2016-12-01 | Ajinomoto Co., Inc. | METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING AN ATTENUATED EXPRESSION OF A gshA GENE |
CN106191146A (zh) * | 2015-05-28 | 2016-12-07 | 味之素株式会社 | 使用具有减弱的gshA基因表达的肠肝菌科细菌生产L‑氨基酸的方法 |
CN106191146B (zh) * | 2015-05-28 | 2021-08-17 | 味之素株式会社 | 使用具有减弱的gshA基因表达的肠肝菌科细菌生产L-氨基酸的方法 |
US11746345B2 (en) | 2015-05-28 | 2023-09-05 | Ajinomoto Co., Inc. | Method for producing an L-amino acid using a bacterium of the family Enterobacteriaceae having an attenuated expression of a gshA gene |
CN111979206A (zh) * | 2019-05-24 | 2020-11-24 | 深圳瑞德林生物技术有限公司 | 固定化融合酶及用其制备谷胱甘肽的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101831397B (zh) | 2012-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104059872B (zh) | 高产n-乙酰氨基葡萄糖代谢工程菌及其构建方法和应用 | |
CN108034645B (zh) | 一种环糊精葡萄糖基转移酶突变体的制备及其应用 | |
CN114107152B (zh) | 一种高产3-岩藻糖基乳糖微生物的构建方法及应用 | |
CN111548979B (zh) | 合成乳酰n-新四糖的重组大肠杆菌及其构建方法与应用 | |
CN116731886A (zh) | 产糖基化虾青素的工程菌及其构建方法与应用 | |
CN107384903B (zh) | 一种海藻糖合酶突变体及其在制备海藻糖中的应用 | |
CN112195110A (zh) | 一株重组米曲霉菌株及其曲酸发酵方法与应用 | |
CN108034667A (zh) | 一种红色红曲霉α-淀粉酶基因、其制备方法及应用 | |
CN106929499A (zh) | 一种定向改造的氨基葡萄糖合酶突变体及其应用 | |
CN110373370A (zh) | 一种耦合atp再生系统的催化体系及其在生产谷胱甘肽过程中的应用 | |
CN113073074A (zh) | 一种高效合成核黄素的基因工程菌及其应用 | |
CN106520715A (zh) | 一种短链脱氢酶及其基因、重组表达载体、基因工程菌及其在虾青素手性中间体合成中的应用 | |
CN101831397B (zh) | 一种大肠杆菌和使用该大肠杆菌制备l-半胱氨酸的方法 | |
CN111411066B (zh) | 一种双途径复合产神经氨酸枯草芽孢杆菌及构建方法 | |
CN113444701A (zh) | 酿酒酵母内源角鲨烯单加氧酶突变体及应用 | |
CN111394410A (zh) | 一种高催化活性神经氨酸合酶及应用 | |
CN104877983B (zh) | 一种海藻糖合酶突变体及其制备与应用 | |
CN102199643A (zh) | 胞二磷胆碱的制备方法 | |
CN109371053B (zh) | 一种红曲色素产生菌株构建方法 | |
CN113881613A (zh) | 一种微生物发酵法生产制备超高分子量透明质酸的方法 | |
CN113493785A (zh) | 一种适用于谷氨酸棒杆菌的高强度启动子及应用 | |
US10465177B2 (en) | Maltooligosyl trehalose trehalohydrolase (MTHase) mutant and application thereof | |
Miguel et al. | Fed-batch culture of recombinant Saccharomyces cerevisiae for glucose 6-phosphate dehydrogenase production | |
CN111411065B (zh) | 一种基于人工双碳源的产n-乙酰神经氨酸的重组菌 | |
CN113249281B (zh) | 一种利用乙醇生产间苯三酚的重组菌及其构建方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: HANGZHOU BIOKING BIOTECHNOLOGY CO., LTD. Free format text: FORMER NAME: HANGZHOU BIOKING BIOCHEMICAL ENGINEERING CO.,LTD Owner name: HANGZHOU BIOKING BIOLOGICAL CO., LTD. Free format text: FORMER NAME: HANGZHOU BIOKING BIOTECHNOLOGY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 311106, Tangqi Town, Yuhang District, Zhejiang City, Hangzhou Province Patentee after: HANGZHOU BIOKING BIOCHEMICAL ENGINEERING Co.,Ltd. Address before: 311106, Tangqi Town, Yuhang District, Zhejiang City, Hangzhou Province Patentee before: Hangzhou crystal biological Polytron Technologies Inc. Address after: 311106, Tangqi Town, Yuhang District, Zhejiang City, Hangzhou Province Patentee after: Hangzhou crystal biological Polytron Technologies Inc. Address before: 311106, Tangqi Town, Yuhang District, Zhejiang City, Hangzhou Province Patentee before: HANGZHOU BIOKING BIOCHEMICAL ENGINEERING Co.,Ltd. |